Bioavailability

 Amount of a substance that becomes available (reaches the target organ or systemic circulation) to an organism's body for bioactivity when introduced through ingestion, inhalation, injection, or skin contact. Rate of bioavailability depends on factors such as the type of the substance and the composition of diet.

 

  • Bioavailability of Liposomes
  • Prodrugs
  • Oral drugs
  • Therapeutic systems
  • Liposomal drug delivery
  • SUPAC: scale-up and for post-approval changes

Related Conference of Bioavailability

December 14-14, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
April 24-24, 2021

2nd International Conference on Nucleic Acids

London, UK
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

Bioavailability Conference Speakers

Recommended Sessions

Related Journals

Are you interested in